4005:TSESumitomo Chemical Co., Ltd. Analysis

National Medical Care Company is trading above its short‑term moving averages with a bullish MACD crossover, while remaining below the long‑term average, suggesting short‑term upside but a longer‑term headwind. The RSI sits in a neutral zone and volume is on the rise, supporting the technical case for a modest near‑term rally toward the identified resistance.
Fundamentally, the stock trades at a price‑earnings multiple well below the industry average and offers a solid dividend yield with a comfortable payout ratio, indicating dividend sustainability. However, operating and free cash flow are negative and debt exceeds cash, flagging liquidity concerns that temper the upside. Analysts maintain a buy consensus with a target price implying notable upside, but the modest revenue growth and cash‑flow deficits suggest caution on the longer horizon.